We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
KeyCorp
KEY
$24.4B
| $47M | 0.02% |
2,696,306
-146,502
| -5% | -$2.58M |
|
552
Avnet
AVT
$7.92B
| $46.9M | 0.02% |
1,127,444
+14,552
| +1% | +$605K |
|
553
MarketAxess Holdings
MKTX
$5.72B
| $46.8M | 0.02% |
167,849
+12,266
| +8% | +$3.16M |
|
554
AtriCure
ATRC
$2.11B
| $46.8M | 0.02% |
532,745
+36,019
| +7% | +$1.5M |
|
555
BioNTech
BNTX
$23.5B
| $46.5M | 0.02% |
309,282
+100,887
| +48% | +$15.5M |
|
556
Jack Henry & Associates
JKHY
$11.1B
| $46.5M | 0.02% |
264,635
-34,929
| -12% | -$6.45M |
|
557
C.H. Robinson
CHRW
$17.5B
| $46.3M | 0.02% |
505,997
-2,346
| -0.5% | -$223K |
|
|
SPLK
558
DELISTED
Splunk Inc
SPLK
| $46.3M | 0.02% |
537,947
-14,258
| -3% | -$1.15M |
|
559
Merit Medical Systems
MMSI
$5.32B
| $46M | 0.02% |
650,949
-69,489
| -10% | -$4.64M |
|
560
Independence Realty Trust
IRT
$4.07B
| $46M | 0.02% |
2,725,849
-428,460
| -14% | -$7.25M |
|
561
Revvity
RVTY
$12.8B
| $45.6M | 0.02% |
325,536
-5,965
| -2% | -$803K |
|
|
AXNX
562
DELISTED
Axonics, Inc. Common Stock
AXNX
| $45.6M | 0.02% |
728,619
-806
| -0.1% | -$53.5K |
|
563
Ziff Davis
ZD
$1.98B
| $45.5M | 0.02% |
575,353
+48,231
| +9% | +$3.88M |
|
564
Charles River Laboratories
CRL
$12.8B
| $45.4M | 0.02% |
208,408
-30,564
| -13% | -$6.67M |
|
565
Sarepta Therapeutics
SRPT
$1.77B
| $45.3M | 0.02% |
349,649
+22,780
| +7% | +$2.64M |
|
566
Iridium Communications
IRDM
$5.29B
| $45.3M | 0.02% |
880,381
-7,471
| -0.8% | -$375K |
|
567
Old National Bancorp
ONB
$10.2B
| $45.2M | 0.02% |
2,513,937
+547,034
| +28% | +$10M |
|
568
TransUnion
TRU
$15.3B
| $45.2M | 0.02% |
796,349
+70,088
| +10% | +$4.11M |
|
569
Broadstone Net Lease
BNL
$4.02B
| $45.2M | 0.02% |
2,787,899
+2,209,360
| +382% | +$36.9M |
|
570
NOV
NOV
$7B
| $45M | 0.02% |
2,155,625
-123,129
| -5% | -$2.58M |
|
571
Liberty Media Series C
FWONK
$25.8B
| $45M | 0.02% |
777,803
-19,819
| -2% | -$1.13M |
|
572
UFP Industries
UFPI
$5.19B
| $44.8M | 0.02% |
565,088
-28,351
| -5% | -$2.17M |
|
573
WillScot Mobile Mini Holdings
WSC
$4.41B
| $44.2M | 0.02% |
977,962
-168,064
| -15% | -$7.54M |
|
|
XIFR
574
XPLR Infrastructure LP
XIFR
$1.08B
| $44.2M | 0.02% |
629,946
+52,294
| +9% | +$3.91M |
|
575
Northern Oil and Gas
NOG
$2.35B
| $44.1M | 0.02% |
1,431,681
+205,323
| +17% | +$6.91M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.